Chronic Condition Management – Health Interactive@50+

From managing diabetes to obesity to hypertension, learn how smart monitoring technologies can ease the burden of complex care management for oneself or a loved one. This panel highlighted 4 companies that are revolutionizing how we coordinate care and maintain wellness in the face of complex health conditions.

Hacking Gamification and Driving Behavior Change Session

Inspiring behavior change in others can be very hard to do. We all know this because we were all stubborn teenagers at one point. However, there are some companies driving behavior change very effectively. They are using fun and engaging games to bring about enhanced mental attention, improved cancer treatments, and much more.

Mango Health: Hacking Gamification and Driving Behavior Change

Jason founded Mango Health with a mission of creating fun and elegant mobile apps that inspire consumers to better manage and improve their health.  Mango Health’s first app is made for the 4 out of 5 people in the U.S. who take a combination of prescription medications, nutritional supplements and over-the-counter drugs each week: the app helps consumers check for dangerous drug interactions and uses game design principles to inspire consumers to stay with prescribed treatment regimens.

iPharma: Mango Health

Jason is the CEO and Co-Founder of Mango Health and uses social game design to manage and improve consumer health. He is here today to share with us a new app used to better manage and compare individual consumer’s well being and health.

iPharma: Innovations in Adherence

For patients, improving medication adherence can both bolster patients’ health as well as revenues. But pharma can’t help realize this objective on its own: adherence is a multi-stakeholder sport. Many of the innovations for adherence improvement are coming from outside of pharma…and sometimes aim to help payers (employers, insurance companies) or others whose incentives are not aligned with those of pharma companies

thumbnail_2_ee5c8e82_8_v1

Chronic Condition Management – Health Interactive@50+

From managing diabetes to obesity to hypertension, learn how smart monitoring technologies can ease the burden of complex care management for oneself or a loved one. This panel highlighted 4 companies that are revolutionizing how we coordinate care and maintain wellness in the face of complex health conditions.

hackinggam

Hacking Gamification and Driving Behavior Change Session

Inspiring behavior change in others can be very hard to do. We all know this because we were all stubborn teenagers at one point. However, there are some companies driving behavior change very effectively. They are using fun and engaging games to bring about enhanced mental attention, improved cancer treatments, and much more.

Mango Health

Mango Health: Hacking Gamification and Driving Behavior Change

Jason founded Mango Health with a mission of creating fun and elegant mobile apps that inspire consumers to better manage and improve their health.  Mango Health’s first app is made for the 4 out of 5 people in the U.S. who take a combination of prescription medications, nutritional supplements and over-the-counter drugs each week: the app helps consumers check for dangerous drug interactions and uses game design principles to inspire consumers to stay with prescribed treatment regimens.

health 2.0 SF

iPharma: Mango Health

Jason is the CEO and Co-Founder of Mango Health and uses social game design to manage and improve consumer health. He is here today to share with us a new app used to better manage and compare individual consumer’s well being and health.

health 2.0 SF

iPharma: Innovations in Adherence

For patients, improving medication adherence can both bolster patients’ health as well as revenues. But pharma can’t help realize this objective on its own: adherence is a multi-stakeholder sport. Many of the innovations for adherence improvement are coming from outside of pharma…and sometimes aim to help payers (employers, insurance companies) or others whose incentives are not aligned with those of pharma companies